Kezar Life Sciences Inc. (NASDAQ: KZR)
$0.69
+0.0440 ( +6.77% ) 432.7K
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Market Data
Open
$0.69
Previous close
$0.65
Volume
432.7K
Market cap
$50.54M
Day range
$0.65 - $0.70
52 week range
$0.54 - $2.55
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 79 | Nov 13, 2023 |
| 8-k | 8K-related | 13 | Nov 13, 2023 |
| 4 | Insider transactions | 1 | Nov 09, 2023 |
| 8-k | 8K-related | 12 | Oct 27, 2023 |
| 8-k | 8K-related | 13 | Oct 03, 2023 |
| 8-k | 8K-related | 13 | Sep 21, 2023 |
| 4 | Insider transactions | 1 | Aug 17, 2023 |
| 8-k | 8K-related | 12 | Aug 14, 2023 |
| 10-q | Quarterly Reports | 74 | Aug 10, 2023 |
| 8-k | 8K-related | 13 | Aug 10, 2023 |